The FASEB Journal
April 1, 2012
Charles W. Schindler, Michael H Baumann, Eric B. Thorndike et al.
The abuse of MDMA (Ecstasy) peaked in the early 2000s, yet reports of MDMA use from emergency room admission data continue to increase. The potential for cardiovascular effects of MDMA to contribute to its acute toxicity has long been recognized. However, the role of MDMA metabolites in mediating the drug's cardiovascular actions has not been studied. Here we employed radiotelemetry to evaluate...
The FASEB Journal
April 1, 2012
Daniel Walker Curry, Kevin Sean Murnane, Leonard Lee Howell
The drug 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) has been shown to increase feelings of closeness and empathy in humans. Despite evidence of MDMA‐induced neurotoxicity, these unusual pro‐social effects have continued to generate interest in the drug's therapeutic potential. Therefore, determining the mechanisms by which MDMA engenders these effects may allow for the development of...
The FASEB Journal
April 1, 2012
Kevin Sean Murnane, Leonard Lee Howell
The neuropharmacology of the sleep and arousal systems involves a complex interplay between multiple neurotransmitter systems. Previous work has downplayed the role of dopamine in sleep and wakefulness, at least in part, because dopamine neurons do not appear to change their firing rates across arousal states. In the present study, we examined the wake promoting effects of amphetamine and...
British Journal of Pharmacology
March 9, 2012
A. C. Parrott
50 citations
In this issue of the BJP , Green et al . suggest that animal data could not be used to predict the adverse effects of 3,4‐methylenedioxymethamphetamine (MDMA) in humans and that MDMA did not produce 5‐HT neurotoxicity in the human brain. This proposal was, however, not accompanied by a review of the empirical evidence in humans. The neuroimaging data on 5‐HT markers in abstinent recreational...
British Journal of Pharmacology
March 8, 2012
Cédric M. Hysek, Yasmin Schmid, Anna Rickli et al.
81 citations
BACKGROUND AND PURPOSE The use of ±3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) is associated with cardiovascular complications and hyperthermia. EXPERIMENTAL APPROACH We assessed the effects of the α 1 ‐ and β‐adrenoceptor antagonist carvedilol on the cardiostimulant, thermogenic and subjective responses to MDMA in 16 healthy subjects. Carvedilol (50 mg) or placebo was administered 1 h...
Neurotoxicology and Teratology
March 5, 2012
Lynn T. Singer, David G. Moore, Sarah Fulton et al.
77 citations
3,4-methylenedioxymethamphetamine (MDMA) or "Ecstasy" is one of the most widely used illicit recreational drugs among young adults. MDMA is an indirect monoaminergic agonist and reuptake inhibitor that primarily affects the serotonin system. Preclinical studies in animals have found prenatal exposure related to neonatal tremors and long-term learning and memory impairments. To date, there are...
Accident; Analysis and Prevention
March 2012
Con Stough, Luke A. Downey, Rebecca King et al.
Illicit drugs such as MDMA and methamphetamine are commonly abused drugs that have also been observed to be prevalent in drivers injured in road accidents. Their exact effect on driving and driving behavior has yet to be thoroughly investigated. Sixty-one abstinent recreational users of illicit drugs comprised the participant sample, with 33 females and 28 males, mean age 25.45 years. The three...
Neurotoxicology
March 2012
Laura Hondebrink, Jan Meulenbelt, Saskia J. Rietjens et al.
Reversal of the dopamine (DA) membrane transporter is the main mechanism through which many drugs of abuse increase DA levels. However, drug-induced modulation of exocytotic DA release by electrical (depolarization) and neurochemical inputs (e.g., acetylcholine (ACh)) may also contribute. We therefore investigated effects of methamphetamine, amphetamine, 3,4-methylenedioxymethamphetamine...
Human Psychopharmacology: Clinical and Experimental
March 1, 2012
Elizabeth Murray, Raimondo Bruno, John Brown
‘Ecstasy’ (3,4‐methylenedioxymethamphetamine) induces impaired functioning in the serotonergic system, including the occipital lobe. This study employed the ‘tilt aftereffect’ paradigm to operationalise the function of orientation‐selective neurons among ecstasy consumers and controls as a means of investigating the role of reduced serotonin on visual orientation processing. The magnitude of...
International Journal of Drug Policy
March 2012
Tibor M Brunt, Raymond J.m. Niesink, Wim van den Brink
A recent decline in MDMA-like substances in ecstasy tablets has been reported by a number of countries in the European Union. This study describes the instability of the ecstasy market in The Netherlands during 2008 and 2009, and investigates whether this had any impact on drug testing or patterns of drug use. The health concerns of drug users handing in drug samples at drug testing facilities...